Saturday , September 22 2018
Home / Letter From The Editor (page 2)

Letter From The Editor

Aug. 21, 2018

As is often the case, once we provide you with a cutting edge interview or new product, many of you ask for a much increased explanation, and a deeper knowledge base. Last week in our Diabetes Mastery newsletter, we had an interview with Dr. Stanley Schwartz where he discussed his …

Read More »

Aug. 18, 2018

Early in my diabetes career, our publisher and my mentor, Steve Freed, had me live like I had diabetes for 2 weeks. I had to check my glucose before every meal, and count my carbs and calculate an insulin dose each time I ate. Although I didn’t have diabetes, he …

Read More »

Aug. 14, 2018

In my editor’s desk on Saturday I used the moniker “insulin dependent type 2 diabetes patients” describing an article our intern had done on adding an SGLT-2 Inhibitor to insulin use. I got some feedback from some of you as to my choice of words, and was this a new …

Read More »

Aug. 11, 2018

This week we have a couple of features that could have been for my wife. The first is a feature that shows the value of e-bikes and fitness, and the second is an item from our PharmD candidate Kennen Munoz Munoz on the addition of an SGLT-2 Inhibitor to insulin …

Read More »

Aug 9, 2018

Over the past couple of years we have seen the use of SGLT-2 Inhibitors increase and we now have 3 different molecules to choose from. There have been studies that show the cardiovascular benefits of the class as well as the benefit of combining them with GLP-1 analogs. This year …

Read More »

Aug. 9, 2018

Every time I look in the endocrinology journals and magazines, the last 4 or 5 pages are always chock full of employment opportunities for endocrinologists all over the country. Many of these ads are the same month after month, giving the indication of just how hard it is to find …

Read More »

August 4, 2018

Have you ever noticed that those of us born in the 50’s and 60’s tend to reminisce about how when we were kids, we had to walk or ride our bikes everywhere, and our parents always would make us play outside after school until dinner was served? We tend to …

Read More »

July 31, 2018

This week it is all about insulin, and for a good reason. Although we have some great oral and non-insulin injectables for the treatment of type 2 Diabetes, and many of these can be used with our type 1 patients, the fact remains that if you have type 1 diabetes …

Read More »

July 28, 2018

This week, it is all about devices, and how they look to change the way we manage diabetes. First off, we have a new device that seems to work similar to the V-Go insulin delivery system. This device becomes the 3rd “mechanical pump” that will be available to patients and, …

Read More »

July 24, 2018

Way back in 2002 we had an article on in our newsletter on the newly discovered INGAP peptide (http://www.diabetesincontrol.com/issue-111-item-19-ingap-peptide-an-initiator-of-beta-cell-growth/ ) This peptide was thought to be able to regenerate beta cells, and early on it looked like a possible cure. Over the past 16 years we have had multiple features on …

Read More »